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Accepted 1 June 2014AbstractObjectives: Regression discontinuity (RD) designs allow for rigorous causal inference when patients receive a treatment based on
scoring above or below a cutoff point on a continuously measured variable. We provide an introduction to the theory of RD and a systematic
review and assessment of the RD literature in medicine, epidemiology, and public health.
Study Design and Setting: We review the necessary conditions for valid RD results, provide a practical guide to RD implementation,
compare RD to other methodologies, and conduct a systematic review of the RD literature in PubMed.
Results: We describe five key elements of analysis all RD studies should report, including tests of validity conditions and robustness
checks. Thirty two empirical RD studies in PubMed met our selection criteria. Most of the 32 RD articles analyzed the effectiveness of
social policies or mental health interventions, with only two evaluating clinical interventions to improve physical health. Seven out of
the 32 studies reported on all the five key elements.
Conclusion: Increased use of RD provides an exciting opportunity for obtaining unbiased causal effect estimates when experiments are
not feasible or when we want to evaluate programs under ‘‘real-life’’ conditions. Although treatment eligibility in medicine, epidemiology,
and public health is commonly determined by threshold rules, use of RD in these fields has been very limited until now.  2015 The
Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).
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Confounding1. Introduction
Regression discontinuity (RD) designs are a rigorous
quasi-experimental method for estimating causal effects
of treatments on outcomes. Whenever a decision rule as-
signs treatment, such as antihypertensive or antiretroviral
therapies, to patients who score higher (or lower) than a
particular cutoff value on a continuously measured vari-
able, such as blood pressure or CD4 count, RD can be used
to estimate the causal effect of the treatment on health and
other outcomes. Like randomization, RD can solve prob-
lems of confounding by unobserved factors, generating un-
biased estimates of the causal effects of a treatment. RD is aConflict of interest: None.
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licenses/by-nc-nd/3.0/).particularly useful research design for medicine, epidemi-
ology, and public health because of the ubiquity of treat-
ments assigned based on a cutoff rule [1]. Physicians
prescribe statins to those with high cholesterol above a
certain cutoff value, use a size cutoff as a guideline for
mole excision, determine treatment for hypertension based
on blood pressure cutoffs, and recommend surgery for
scoliosis when spinal curvature exceeds some threshold of
severity. In addition, RD has desirable practical characteris-
tics. When a treatment has already become the standard of
care, it may not be possible to conduct a randomized
controlled trial (RCT), but RD can provide strong causal
evidence on treatment effectiveness in cases where there
is little or no experimental evidence or where the existing
evidence is of questionable internal or external validity
[2]. Additionally, RD may be less costly than experimental
methods because it can be implemented using data that is
commonly collected in patient files and administrative data.
Cohort studies that collect information on a continuousess article under the CC BY-NC-ND license (http://creativecommons.org/
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 Regression discontinuity (RD) is a quasi-
experimental study design that is well suited formed-
ical, epidemiologic, and public health research. RD
identifies causal effects by exploiting a treatment
assignment practice that is common in these fields:
the assignment of treatment based on whether a pa-
tient scores above or below a cutoff point on a contin-
uously measured variable, such as blood pressure,
cholesterol, or CD4 count.
 RD has several advantages over randomized
controlled trials (RCTs). In particular, it can be
used to evaluate interventions that have become
standard practice without preceding RCTs or when
there is doubt that trial-based evidence can be
generalized to routine health care in particular con-
texts. In this article, we present the underlying the-
ory and compare RD to randomized trials and
traditional cohort studies.
 To date, RD has been underutilized in medicine,
epidemiology, and public health. We identified 32
studies in PubMed, 13 of which are published in eco-
nomics or health economics journals. Very few arti-
cles in our systematic review use RD to study the
effect of clinical interventions on health. The studies
have been of overall good quality, but further im-
provements are possible. Guidelines for implement-
ing and presenting RD studies can help encourage
utilization of this study design in medicine, epidemi-
ology, and public health. In this paper, we provide
guidance: in addition to showing the relationship be-
tween the assignment variable and the outcome, high
quality RD studies should include a discussion of the
treatment assignment rule, a histogram of the assign-
ment variable, a discussion of how a particular study
meets the conditions necessary for valid RD estima-
tion, covariate balance tests, and robustness checks
of the RD estimation approach.
 There is significant potential for RD to generate
strong causal evidence using existing clinical,
administrative, and programmatic cohort data.
Data collection guidelines for clinical and epide-
miologic cohort studies and administrative data
in public health should be updated to make RD
analysis feasible whenever possible, for example,
by retaining data on patients not yet eligible for
treatment.
diagnostic criterion, the treatment patients receive, and the
outcomes in both treated and nontreated groups will have
the data necessary to implement RD analyses. A further
E. Moscoe et al. / Journal of Clinadvantage of RD is that it can be easily graphically pre-
sented, allowing results to be shared widely with policy
makers and implementing organizations.
RD was first used in the field of educational psychol-
ogy by Thistlewaite and Campbell [3] in 1960. The design
was introduced to statistics by Rubin [4]. Berk and Rauma
[5] extended the model to dichotomous variables using lo-
gistic models. In a recent paper Bor et al. [1] extended RD
to the case of survival analysis. RD has become widely
used in economics since the 1990s [6e8]. Studies of the
impact of incumbency on electoral outcomes [9], the ef-
fects of military conscription on earnings [10], and the
relationship between class size and student performance
[11] showed that RD could generate important results in
a broad range of settings. A number of important ad-
vances in the theory of RD have come out of the recent
economics literature [12,14]. Economists have also used
RD designs to address questions that are of interest to ep-
idemiologists and public health researchers. For example,
Almond et al. [15] estimated the causal effect of intensi-
fied medical treatment given to very low-birth-weight ba-
bies (weighing less than 1,500 g) on 1-year mortality.
Using the cutoff age of 21 for legal alcohol purchases,
Carpenter and Dobkin [16] evaluated the effect of alcohol
consumption on mortality.
The goals of this article are (1) to provide an introduction
to the theory of RD and a guide for implementation and ‘‘best
practice’’ in the context of medicine, epidemiology, and pub-
lic health and (2) to systematically review and evaluate the use
of RD in these fields of research, that is, the ‘‘current prac-
tice.’’ We further discuss potential applications and limita-
tions of RD in epidemiology and public health.2. Fundamentals of RD designs
RD can be used when clinical practice or public health
programs use a cutoff point on a continuous variable as
the decision rule to assign treatment or program eligibility.
Treatment assignment following such a rule can be either
deterministic (every patient on the one side of the cutoff
value receives the treatment and every patient on the other
side does not) or probabilistic (the probability of receiving
the treatment is higher on the one side of the cutoff value
than on the other side). The first case is called ‘‘sharp’’
RD and the second ‘‘fuzzy’’ RD. We present both cases
in the following paragraph.
Like a RCT, RD is more than a method of data analysis: it
is a description of the data-generating process when a
continuously measured variable has a cutoff point that deter-
mines treatment status. Under certain conditions, it is
possible to infer that a difference in outcomes is the causal
result of the assignment variable’s cutoff point. Researchers
have invoked different assumptions to identify causal effects
in RD designs [17]. Early discussions of RD emphasized
global average treatment effects and required very strong
functional form assumptions [4]. Most recent RD
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effects ‘‘at the threshold’’, for which the key assumption is
continuity in potential outcomes, i.e. that there are no unob-
served confounders at the threshold. As we approach the
cutoff value from above and below, the patients in the two
groups become more and more alike, on both observable
and unobservable characteristics; in a small area around
the threshold, the only difference is in treatment assignment.
In some settings, it is remarkable how easily the continuity
assumption is met. If there is random noise in measurements
of the assignment variable and it cannot be precisely manip-
ulated, then continuity in potential outcomes is guaranteed
(in expectation) [13]. Because of the random noise in an
individual’s value of the assignment variable, whether a per-
son near the cutoff falls above or below the cutoff is essen-
tially random. We can thus interpret the difference in
outcomes between the people just above the cutoff and those
just below it as a true causal effect of the treatment. Although
not all RD designs have this ‘‘local randomization’’ interpre-
tation, it is often justified in clinical settings, where blood
glucose levels, CD4 counts, and blood pressure are measured
with substantial error [17].
2.1. Assumptions and validity conditions
The conditions and assumptions necessary for causal infer-
ence in RD are relatively weak compared with other quasi-
experimental methods. Furthermore, when the focus is on
local treatment effects at the threshold, the critical assump-
tions can be supported using the available data, something that
is not possiblewithmostother quasi-experimental approaches.
The three conditions for a valid RD are as follows:
2.1.1. The decision rule and cutoff value are known
Researchers must know the cutoff value of the variable
used to assign treatment, known as the assignment vari-
able. Throughout this section, we will use the letter Z to
designate the assignment variable. Researchers must also
know whether treatment is assigned when Z is below or
above the cutoff. It is also helpful to know whether other
factors (eg, clinical judgment in addition to a laboratory
measure representing Z ) contribute to the decision to
treat. In such cases, the ‘‘fuzzy’’ variant of RD must be
used, in which intent-to-treat effects are estimated and
scaled by the level of compliance with the threshold rule
to obtain complier average causal effects (CACE) for
those receiving the treatment. In both the ‘‘sharp’’ and
the ‘‘fuzzy’’ variant of RD, we estimate a causal effect
local to the population close to the cutoff value.
2.1.2. The assignment variable is continuous near the
cutoff value
The assignment variable Z may be any continuous vari-
able that is measured before treatment, is not affected by
the treatment, and determines treatment at some cutoff
point. Contrary to other quasi-experimental methods thatattempt to control for unobserved confounders (eg,
difference-in-difference analysis), there is no area of over-
lap in sharp RD where observations with differing treat-
ment status have the same values of Z. Hahn et al. [12]
show that without this area of overlap, continuity in Z near
the cutoff is sufficient to obtain unbiased estimates of the
TE. Visual inspection of the data can confirm that Z is
continuous at the cutoff.2.1.3. Potential outcomes are continuous at the
threshold
For causal effects to be identified, patients must be
similar just above and below the threshold. This is neces-
sary to ensure that their potential outcomes (outcomes if
all were or were not treated) would be similar immediately
on either side of the threshold. More formally, the condi-
tional distributions of potential outcomes with respect to
Z are continuous at the threshold.
The continuity assumption would be violated if the spe-
cific cutoff point was determined because of an underlying
discontinuity in the relationship between Z and the
outcome. For example, if the cutoff for treatment assign-
ment to antihypertensive medication was determined
because a physiological phenomenon that is correlated with
the outcome of interest, for example, cardiovascular mortal-
ity, occurred precisely at the cutoff, then reverse causality
could confound the analysis. Similarly, there must be no
unobserved confounders that are discontinuously associated
with the outcome at the cut-off. For example, when esti-
mating the effect of differences in cigarette taxes on smok-
ing behavior using distance from a state line as the
assignment variable, the analysis may be confounded by
other aspects of the state policy environment. Plots of other
covariates around the cutoff and knowledge about how the
cutoff rule is established can help to confirm that the
discontinuity in Y is caused only by the cutoff and not by
another factor.
The most compelling RD design occurs when there is
random noise in measurements of the assignment variable
(such as CD4 counts, but not distance to an administrative
boundary). This is common in clinical applications. In this
case, the assumption of continuity in potential outcomes is
trivially satisfied (in expectation) under a much more
straightforward and testable assumption: that patients have
only imperfect control over the value of assignment vari-
able and cannot precisely manipulate its value. In the
simplest case, patients have no control over Z (eg, birth
date) and therefore cannot manipulate their treatment sta-
tus. However, RD can still be applied in scenarios where
patients have some degree of control over Z, as long as this
control is incomplete, as in a case where adherence to
medication is correlated with, but does not perfectly deter-
mine, Z. Clinical and public health practice in particular
settings will affect the degree to which patients and pro-
viders influence their measured value of Z. The presence
135E. Moscoe et al. / Journal of Clinical Epidemiology 68 (2015) 132e143of manipulation can be identified in the data by assessing
the presence of bunching in the density of Z at the cutoff.
2.2. Inference and estimation in sharp RD
When treatment is a deterministic function of the assign-
ment variable, we will have the simplest form of RD
design. Let T be the treatment, Y be the outcome, and Z
be the forcing variable. The fundamental problem of causal
inference is that we do not observe Yi when Ti 5 0 and
Ti 5 1, denoted Yi(1), Yi(0). RCTs solve this by estimating
an average casual effect (ACE) for the population. In the
sharp RD design, we observe T 5 1 on the one side of
the cutoff and T 5 0 on the other side. Near the cutoff,
we examine the TE as Z approaches the cutoff C from
either side:ACESRD5 lim
z[c
E½Yið1ÞjZi5 z  lim
zYc
E½Yið0ÞjZi5 z:This is equal toACESRD5E½Yið1Þ  Yið0ÞjZi5 c:
Under the assumptions aforementioned, the outcome Y
would be continuous in the absence of treatment. Instead,
c introduces randomness by assigning people just above
(or below) the cutoff to the treatment. The direction and
magnitude of the difference in Y above and below c gives
the ACE. In RD analysis, the ACESRD is a local effect,
meaning that it is valid near the cutoff, because the identi-
fication is due to the local randomness resulting from the
cutoff point. To estimate the ACESRD in practice, regression
models allow for different slopes on either side of the
cutoff:Yi5b0 þ b1Ti þ b2ðZi  cÞ þ b3TiðZi  cÞ þ εi
where T 5 1 when the individual is treated and b1 is the
ACESRD (the ‘‘jump’’ at the cutoff point). b2 is the slope
in absence of treatment, and the interaction term’s coeffi-
cient, b3, allows for a different relationship between Z
and Y on the other side of c. Higher order terms and other
covariates can be included in the model and the model
should be estimate for a wide range of bandwidths (win-
dows of data) around the threshold. In the next section,
we outline the steps for implementing RD.
2.3. Inference and estimation in fuzzy RD
The fuzzy RD design is similar to a randomized exper-
iment with imperfect treatment compliance. The treatment
assignment indicator, Z O c, determines treatment status
but only probabilistically. Some patients would always take
up the treatment, regardless of treatment assignment; other
patients would never take up the treatment even if as-
signed. Recall the TE from a sharp RD, ACESRD. In the
fuzzy RD design, ACESRD is equivalent to the intent-to-
treat (ITT) effect, that is, the causal effect of treatmentassignment on the outcome, which we will call ITTFRD.
As in a randomized experiment, the causal effect of treat-
ment status itself can be estimated for the subpopulation
of patients whose treatment decision was determined by
their treatment assignment (so-called compliers). To obtain
this complier average causal effect (CACEFRD), we scale
this by the probability of treatment on each side of the
cutoff:CACEFRD5
lim
z[c
E½Yið1ÞjZi5 z  lim
zYc
E½Yið0ÞjZi5 z
lim
z[c
P½Ti51jZi5 z  lim
zYc
P½Ti51jZi5 zNote that when the denominator equals 1, treatment is
completely determined by the cutoff point and the fuzzy
RD estimator equals the sharp RD estimator. When there
is no discontinuity in probability of treatment, that is, the
denominator equals zero, CACEFRD is undefined.
In practice, we can use the same regression model as
with the sharp analysis, with one modification. We use
treatment assignment (Zi above c ) as an instrumental
variable (IV) to predict actual treatment status Ti [12]. This
instrument will not have the usual weaknesses of IV anal-
ysis, namely reliance on the untestable assumption that
the instrument is as good as randomly assigned. As with
any IV, careful attention must be paid to the assumption
of excludability (ie, the instrument only affects the outcome
through its effect on treatment status).
2.4. RD in practice: a step-by-step guide to
implementation
To structure the description of the practical process of
implementing RD, we have divided the RD analysis into
four steps.
1. Determine feasibility of RD design: In considering a
RD strategy, researchers should determine that it is
feasible given the available data and indicate which
type (‘‘sharp’’ or ‘‘fuzzy’’) is appropriate. The fuzzy
implementation of RD allows estimation even when
the treatment assignment is not deterministically gov-
erned by the assignment variable. We recommend
that researchers verify and demonstrate that the data
contain the following:i. Continuous eligibility measure: The assign-
ment variable is measured and reported
continuously.
ii. Universal outcome assessment: The outcomes
must be observed for all patients, independent
of whether they were assigned the treatment
or not, similar to other prospective studies.
iii. Treatment assignment rule: Precise informa-
tion on how treatment is assigned to patients
(either above or below and either probabilisti-
cally or deterministically) is needed to
Fig. 1. Probability of receiving treatment for fuzzy (A) and sharp (B) designs.
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‘‘fuzzy.’’ Presenting a plot of the assignment
variable against treatment status, which dis-
plays the distribution of treatment assignment,
demonstrates this for the readers (see Fig. 1).2. Consider covariate balance and possible manipulation
of treatment status: Using a histogram of the assign-
ment variable, Z, researchers can confirm that there
is no ‘‘bunching,’’ (Fig. 2) which would indicate
manipulation of treatment status [18]. To confirm that
the groups on either side of the cutoff are comparable
and that other observed factors are not discontinuous
at the cutoff, it is useful to report covariate balance
tests (or scatter plots) of Z on several pretreatment co-
variates [6]. RD designs rely on the local randomness
resulting from cutoff-based treatment allocation. To
support this, it is important to demonstrate that indi-
viduals on each side of the cutoff are similar with
respect to pretreatment covariates (age, income, andFig. 2. Histogram of assignment variable.educational attainment, for example) by testing for
balance on these variables around the cutoff point.
Smooth distributions of covariates also help to estab-
lish that there is no manipulation of treatment status
similar to an RCT.
3. Visually check for a treatment effect: A plot of Y on
the assignment variable visually confirms the discon-
tinuity for the reader (see Fig. 3). Visual inspection
that reveals a visible jump at the cutoff indicates a
nonzero treatment effect, whereas continuity at the
cutoff indicates a null effect. When outcomes are
discrete, proportions can be estimated in bins. The
shape of the scatter plot can indicate whether interac-
tion terms and higher order terms should be included
in the regression model.
4. Fit the regression models to estimate the TE: It is
possible to either estimate a local linear regression us-
ing only the data near the cutoff or estimate a regres-
sion model using the full data set, as in Fig. 4. This
decision can be made based on data availability and
other factors, but in practice, it may be best to esti-
mate multiple specifications of both methods. When
using local linear regression, use specifications with
data spanning different distances from the cutoff
(bandwidths) to establish robustness of the effect size
estimate [14]. When using the full data, flexible
models with higher order polynomial terms may be
compared with linear models. It is also possible to
include interaction terms in the regression equation
to allow for differences in the relationship between
Z and Y above and below the cutoff, which may occur
if the treatment changes the relationship.
As with any regression model, misspecification of the
functional form can cause incorrect estimation. However,
this is a practical rather than a theoretical problem for RD.
With enough data, a simple difference in means near the cut-
off would give the TE without requiring any assumptions of
functional form. The use of local regressions with small
Fig. 3. Plot of outcomes for fuzzy (A) and sharp (B) designs.
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functional form assumptions and acts as a robustness check
to globalmodels, and better data collection procedures (over-
sampling near the cutoff) can improve power at narrower
bandwidths. The local nature of RD estimates means that
extrapolation to observations far from the cutoff may not
be valid, but sufficient robustness checks can confirm that
the local estimates are not artifacts of model specification.3. Systematic review of the literature in PubMed
To establish the frequency and quality of RD use in the
epidemiology and public health literature, we performed a
systematic review of the PubMed literature. Our aim was to
identify empirical publications that use RD to estimate the
causal effect of an exposure on a health outcome. To identify
other terminology that may refer to RD-type designs, we
examined the MeSH terms for study design and method
and checked the MeSH terms associated with RD studies.
No other label or terminology was found. We therefore
chose the broadest search algorithm that would return
RD studies: ‘‘regression discontinuity’’ OR (‘‘regression’’Fig. 4. Plot of outcomes with fitted regressionAND ‘‘discontinuity’’). This search term returned 193
unique records in PubMed as of December 8, 2014, cata-
logued in PubMed between May 1981 and December 8,
2014. We selected records for final review that met the
following criteria. First, we rejected articles if they were sys-
tematic reviews, case studies, or method articles without an
empirical application, or any other empirical strategy. A total
of 134 articles were excluded based on these criteria. Second,
we rejected articles that did not examine effects on health
outcomes. We defined health outcomes broadly to include
mortality, morbidity, and diagnosticmarkers, for bothmental
and physical health. Based on this criterion, we excluded a
further 27 articles, yielding a final database of 32 articles in-
dexed in PubMed that used RD as an empirical approach to
assess the effect of an exposure on a health outcome.
Next, we reviewed the articles to determine whether they
included descriptions of the elements that are important for
successful implementation of RD design, based on the val-
idity conditions and the implementation guide described in
section 2.4. We report whether these elements are present
or absent as an assessment of study quality. In particular,
we examined whether the studies included the followinglines for fuzzy (A) and sharp (B) designs.
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demonstrate that the data and context are appropriate for a
valid RD study (validity conditions), and the last one ad-
dresses the practical problem of sensitivity to the functional
form specification:
1. A discussion of the RD validity conditions in the
context of the particular study.
2. A clear presentation or discussion of the assignment
rule.
3. Covariate balance tests for treated and nontreated
groups showing that there is no discontinuity in pre-
treatment variables.
4. A histogram of the assignment variable that shows no
bunching of the data around the cutoff to demonstrate
no manipulation of treatment status.
5. Multiple RD estimation specifications to check for
robustness, including alternative functional forms,
nonparametric regression, and local linear regression
with varying bandwidths.Table 1. PubMed articles with health outcomes using regression discontinu
Authors Year Journal
Albouy and Lequien [23] 2009 Journal Health Economics
Almond et al. [15] 2010 Quarterly Journal of Economics
Andalon [24] 2011 Health Economics
Anderson et al. [25] 2011 Journal of Health Economics
Arcand and Wouabe [26] 2010 Health Economics
Banks and Mazzonna [27] 2012 Economics Journal
Behrman [28] 2014 Social Science and Medicine
Bor et al. [1] 2014 Epidemiology
Callaghan et al. [29] 2014 Drug and Alcohol Dependence
Callaghan et al. [30] 2013 American Journal of Public Health
Callaghan et al. [31] 2013 Addiction
Carpenter and Dobkin [16] 2009 AEJ: Applied Economics
Carpenter and Dobkin [32] 2011 Journal of Economic Perspectives
Chen et al. [33] 2013 PNAS
Conover and Scrimgeour [34] 2013 Journal of Health Economics
De La Mata [35] 2012 Health Economics
Deza [36] 2014 Health Economics
Flam-Zalcman et al. [37] 2012 Intl J Psych Research
Fletcher [38] 2014 Biodemography and Social Biology
Glance et al. [39] 2014 JAMA Surgery
Gormley et al. [40] 2005 Developmental Psychology
Huang and Zhou [41] 2013 Social Science and Medicine
Jensen and Wust [42] 2014 Journal of Health Economics
McFarlane et al. [43] 2014 Schizophrenia Bulletin
Miller et al. [44] 2013 AEJ: Applied Economics
Nishi et al. [45] 2012 Bulletin of the WHO
Pierce et al. [46] 2012 Pers Soc Psych Bulletin
Sloan and Hanrahan [47] 2014 JAMA Ophthalmology
Smith et al. [48] 2014 Canadian Medical Association Journ
Sood et al. [49] 2014 BMJ
Weaver et al. [50] 2010 Journal of Traumatic Stress
Y€or€uk and Y€or€uk [51] 2012 Social Science and Medicine
Abbreviations: BMI, body mass index; HIV, human immunodeficiency vi
tional Academy of Sciences; Intl J Psych Research, International Journal of M
ical Association; WHO, World Health Organization; Pers Soc Psych B
papillomavirus; BMJ, British Medical Journal.
See references for full citation information: [1,15,16,23e51].Table 1 reports the 32 articles (of 193) that met the in-
clusion criteria [1,15,16,23e51]. Of the 32 studies, 13 were
published in economics or health economics journals, five
were published in psychology or psychiatry journals, and
the remaining 14 were published in health journals (i.e.,
in epidemiology, public health, or medical journals). Nine
articles were published prior to 2012, six in 2012, six in
2013, and eleven in 2014. The publications in economics
and health economics journals addressed questions of rele-
vance for epidemiology, such as the effect of education on
body mass index [25] and mortality [23], the impact of
teacher training on students’ fertility and high-risk sex be-
haviors [26], and the effects of alcohol consumption on
mortality [29e31]. Table 2 lists how well the published
studies adhered to the elements of good RD practice. To
summarize the findings, the final column of the table dis-
plays the total number of included elements for each article,
assigning one point for each element (of five possible). Of
the 32 studies, seven included all five elements. All studiesity designs
Study topic
Effect of education on mortality
Returns to treatment of low-birth-weight newborns
Effect of Oportunidades on obesity
Effect of schooling on children’s BMI
Effect of teacher training on HIV prevention
Effect of education on old-age cognitive ability
Effect of primary schooling on HIV status
Effect of early vs. deferred HIV treatment on mortality
Effect of legal drinking age on mortality
Effect of legal drinking age on alcohol-related morbidity
Effect of legal drinking age on inpatient morbidity
Effect of alcohol consumption on mortality
Minimum legal drinking age and public health
Effect of air pollution on mortality
Health effects of minimum legal drinking age
Effect of Medicaid eligibility on coverage, utilization, and health
Effect of alcohol use on drug consumption
Effect of criterion-based increase in alcohol treatment
Effect of genetics on stress response
Effect of hospital report cards on mortality
Effect of universal pre-kindergarten on cognitive development
Effect of education of cognition
Effect of Caesarean section on maternal and child health
Effect of treatment program on psychosis onset
Effect of insurance on health spending, utilization, and health
Health effects of patient cost-sharing
Effect of income disparity in marriage
Effect of new therapies on vision loss among elderly patients
al Effect of HPV vaccine on sexual behavior
Effect of health insurance on mortality
Effect of cognitive-behavioral therapy on trauma symptoms
Effect of alcohol on psychological well-being
rus; AEJ, American Economic Journal; PNAS, Proceedings of the Na-
ethods in Psychiatric Research; JAMA, Journal of the American Med-
ulletin, Personality and Social Psychology Bulletin; HPV, human
Table 2. Inclusion of key elements in regression discontinuity publications
Author Year
Discussion of RD
validity conditions
Discussion of
assignment rule
Covariate
balance tests
Histogram of
assignment variable
Robustness
checks Total (0-5)
Albouy and Lequien [23] 2009 U U ✗ ✗ U 3
Almond et al. [15] 2010 U U U U U 5
Andalon [24] 2011 U U U U U 5
Anderson et al. [25] 2011 U U ✗ ✗ ✗ 2
Arcand and Wouabe [26] 2010 U U U ✗ U 4
Banks and Mazzonna [27] 2012 U U U ✗ U 4
Behrman [28] 2014 U U ✗ ✗ U 3
Bor et al. [1] 2014 U U U U U 5
Callaghan et al. [29] 2014 U U ✗ ✗ U 3
Callaghan et al. [30] 2013 U U U ✗ U 4
Callaghan et al. [31] 2013 ✗ U ✗ ✗ U 2
Carpenter and Dobkin [16] 2009 U U U ✗ U 4
Carpenter and Dobkin [32] 2011 U U ✗ ✗ ✗ 2
Chen et al. [33] 2013 U U U U U 5
Conover and Scrimgeour [34] 2013 ✗ U ✗ ✗ U 2
De La Mata [35] 2012 U U U ✗ U 4
Deza [36] 2014 U U U ✗ U 4
Flam-Zalcman et al. [37] 2012 U U ✗ ✗ ✗ 2
Fletcher [38] 2014 U U U U U 5
Glance et al. [39] 2014 ✗ U U ✗ U 3
Gormley et al. [40] 2005 U U U ✗ U 4
Huang and Zhou [41] 2013 U U ✗ ✗ U 3
Jensen and Wust [42] 2014 U U U ✗ U 4
McFarlane et al. [43] 2014 U U U ✗ U 3
Miller et al. [44] 2013 U U U U U 5
Nishi et al. [45] 2012 ✗ U ✗ ✗ ✗ 2
Pierce et al. [46] 2012 U U U ✗ U 5
Sloan and Hanrahan [47] 2014 ✗ U U ✗ ✗ 2
Smith et al. [48] 2014 U U U ✗ U 4
Sood et al. [49] 2014 U U U ✗ U 4
Weaver et al. [50] 2010 ✗ U U ✗ ✗ 3
Y€or€uk and Y€or€uk [51] 2012 U U U ✗ U 4
Abbreviation: RD, regression discontinuity.
See references for full citation information: [1,15,16,23e51].
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included a discussion of the RD validity conditions. The
most commonly omitted element was a histogram (or
description of the distribution) of the assignment variable
(25 of 32 omitted).4. Discussion
There are many opportunities to implement RD designs
in medicine, epidemiology, and public health, where treat-
ments are often assigned based on threshold rules. Clinical
cohort studies often include the three data elements
required for implementation of this technique: information
on a continuous diagnostic criterion (Z ) used with a cutoff
rule to assign treatment, information on whether treatment
was received, and outcomes for both treated and untreated
individuals. RD is a powerful quasi-experimental method
with several advantages over other commonly used ap-
proaches for causal inference from observational data, as
illustrated by the examples in Box 1. RD’s greatest strength
is its ability to achieve balance on unobserved factorsd
much like an RCT. In contrast, the methods based on
regression-adjustment and matching that are commonlyused to analyze clinical cohorts must rely on the strong
assumption that there are no unmeasured confounders.
Further, inference using RD relies on weaker assumptions
than most other quasi-experimental designs, such as IVs
and difference-in-difference approaches [6].
RD even has several advantages over randomized
controlled experiments, and in some cases might be consid-
ered as an alternative to the clinical trial: First, RD offers an
opportunity to exploit preexisting data and therefore is less
costly than experimental methods. As discussed above, the
data required are often already collected in cohort studies
or could be collected or through relatively simple and inex-
pensive modifications to current collection procedures.
Alternatively, cohort data can be linked to existing admin-
istrative data, e.g. national registries. Second, the local na-
ture of the RD estimator has advantages in interpretability
over a population average effect because it reflects the
TE on the marginal unit near the cutoff point. In cases
where we are interested in the impact of the cutoff itself,
and in optimizing threshold rules, this is precisely the quan-
tity we want to estimate. For example, it would be ideal for
whether persons on the margins of eligibility for a supple-
mentary feeding program are benefiting from the program
Box 1 Example study question where RD may be useful
What is the survival impact of early vs. deferred antiretroviral therapy (ART) for HIV patients in sub-Saharan Africa?
Study design Description Strengths and weaknesses
Randomized controlled
trial [19,20]
Randomly assign HIV patients to immediate
(200  CD4 ! 350) vs. deferred (CD4 !200)
ART. Collect survival data for treated and
controls; compare using KaplaneMeier estimator
and hazard regression models. Monitor CD4
counts of control subjects and initiate them on
ART when eligible to determine efficacy of early
vs. deferred ART.
Strengths
1. Randomization guarantees balance on both
observed and unobserved covariates, in
expectation.
2. Valid counterfactual; RCTs can estimate
intent-to-treat (ITT) and complier average
causal effects (CACE).
Weaknesses
1. Often a treatment is protective, but the effect
size or its generalizability across settings is
unknown. If clinical equipoise cannot be met,
then an RCT would be unethical.
2. Conducted in controlled settings to assess
efficacy but may not be informative of real-
world effectiveness.
3. RCTs are expensive, logistically difficult.
4. Because of screening criteria and opt-in
consent, study subjects may not be
representative of population of interest.
Traditional cohort
study [21,22]
Nest additional data collection in existing HIV
treatment program. Compare survival among HIV
patients who initiate ART at different CD4 counts.
Control for available baseline predictors in
hazard regression models to reduce
confounding.
Strengths
1. Relatively easy to implement and
inexpensive.
2. Large, representative samples can be
obtained.
3. Can evaluate treatment outcomes in real
world settings
Weaknesses
1. Cannot control for unobserved confounders,
correlated with both ART delay and survival.
2. Studies typically exclude HIV patients who
seek care but do not initiate ART, leading to
selection bias.
3. No valid counterfactual, no causal effect.
Regression discontinuity
design [1]
Nest additional data collection in existing HIV
treatment program. Assess survival among
patients with different CD4 counts at initial
presentation. Follow-up all patients. Exploit
threshold rule (start ART if CD4 !200) to obtain
causal effect. Compare predicted survival for
patients immediately above vs. below the
treatment threshold using hazard regression
models. Assess effects at different thresholds
that have been implemented in different settings,
in order to optimize treatment guidelines.
Strengths
1. Relatively easy to implement and
inexpensive.
2. Large, representative samples can be
obtained.
3. Informative of real-world effectiveness.
4. Random variability in measured CD4 counts
yields local randomization at threshold;
balance is achieved in both observed and
unobserved factors, in expectation.
5. Includes all patients who seek care and have
a CD4 test.
6. Valid counterfactual; estimates ‘‘local’’ ITT
and CACE.
Weaknesses
1. Local causal effects identified at the threshold
so may not be generalizable to CD4 counts far
from the threshold. But local effect of
marginal change in treatment threshold is
often of interest.
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However, the local nature of the RD estimator does mean
that it may not be generalizable to observations far from
the cutoff. Third, when ethical, political, or technical rea-
sons preclude random allocation of treatment, RD analyses
may be used to establish causal effect sizes if the treatment
in question is assigned via a cutoff rule. In particular, such
an opportunity for RD analysis will be valuable when a lack
of equipoise, existing clinical practice, or political con-
straints make randomized trials infeasible [52]. For
example, a study in our systematic review by Weaver
et al. [50] uses RD to evaluate a program that assigns treat-
ment based on severity of symptoms and cites the ethical
constraints of conducting an experiment with a vulnerable
population suffering from posttraumatic stress as a motiva-
tion for the use of a RD design. Fourth, RD is often better
for estimating ‘‘real-life’’ effectiveness as opposed to clin-
ical efficacy in the highly controlled settings of a random-
ized experiment and can be used for evaluation after a
policy is already implemented. For impact evaluations of
large-scale public health programs, governments and policy
makers may be more concerned with the de facto effects as
opposed to the effects under ideal conditions. In most of
these cases, the fuzzy form of RD will be used because
the cutoff will only determine treatment status for some pa-
tients. Studies comparing the performance of RD to ran-
domized trials find that it performs well [53,54].
Given its advantages vis-a-vis other study designs, it is
surprising that RD has not been more widely used in med-
icine, epidemiology, or public health. With only two excep-
tions [1,15], all of the 32 RD studies in this systematic
review aimed to establish the effectiveness of social pol-
icies or mental health interventions, despite the potential
of RD to be used to answer many research questions about
clinical interventions to improve physical health. One of the
only two studies applying RD to study an intervention to
improve physical health was published in an economics
journal [15]. Almond et al. [15] use the low birth weight
threshold rule to determine eligibility of medical interven-
tions for low birth-weight babies on infant mortality. The
other study applying RD to study an intervention to
improve physical health was published in an epidemiology
journal. Bor et al. [1] exploit the CD4 count threshold rule
used to determine eligibility for HIV treatment to estimate
the causal effect of immediate vs. deferred antiretroviral
therapy on mortality.
The review results demonstrate increasing interest in RD
in recent years. Almost one third of all studies using RD
included in our systematic review were published in
2014. However, almost all of the recent studies, including
those in health journals, aimed to establish the effectiveness
of social policies, rather than the effectiveness of clinical
interventions. The potential of RD to generate insights on
the effectiveness of a wide range of clinical interventions
aiming to improve physical health yet is to be realized.
Although our search for RD studies yielded 193 recordsin PubMed, a search for the MeSH term ‘‘randomized
controlled trial’’ yielded 490,086 records over the same
period. Yet, there are many circumstances where RD is
preferred to randomized trials, either for theoretical reasons
(the local nature of the RD estimator) or practical reasons
that preclude usage of RCTs. RDs can answer questions
that experiments cannot and that other quasi-experimental
methods cannot answer as convincingly, such as the local
effect of changing diagnostic guidelines or impact evalua-
tions of programs as they are truly implemented in the
context of health system imperfections.
One possible explanation for the underutilization of RD
designs in epidemiology, medicine, and public health is a
lack of agreement on the underlying principles and termi-
nology, as Cook [8] argues and our results in Table 2 sug-
gest. In 1996, the American Journal of Public Health
published two articles and a commentary that urged the
use of a risk-based allocation design [55e57], which is a
subtype of RD where treatments are allocated based on
clinically measured risk. The principle underpinning this
design is very similar to RD, but the relationship with the
broader class of RD studies is not made explicit.
Interestingly, a similar design, interrupted time series
(ITS), has been widely used in epidemiology to estimate
the effects of policy changes. In the most rigorous ITS
scenariodwhen a policy is implemented very rapidly and
short-term outcomes are assessed at frequent intervalsd
ITS can be interpreted as a sub-type of the RD design, in
which calendar time is the assignment variable Z and the
cutoff occurs when a new policy is implemented. The
acceptance of ITS studies indicates that the basic concepts
of RD are already familiar to researchers in epidemiology
and public health but that the intuition behind ITS has
not been generalized to the full range of applications that
can be analyzed with an RD design, in which threshold
rules on other continuous baseline characteristics influence
treatment assignment.
The results of our systematic review suggest that despite
an overall good quality of RD articles in medicine, epide-
miology, and public health, there are several elements that
are frequently not presented. We identified validity condi-
tions for RD designs and guidelines on which elements
should always be presented to support the validity of the
design. Without these, the articles cannot establish as
convincingly that their data and analysis meet the condi-
tions for a valid RD study. Currently, these conditions
and their corresponding empirical recommendations have
not been codified in medicine, epidemiology, or public
health in contrast to the STROBE Statement for reporting
of observational studies and the CONSORT Statement for
reporting RCTs. Standardization of the presentation of
RD studies in these fields would enable readers to more
readily discern the quality of these studies and would
elevate the level of quality of RD analysis and their accept-
ability in the literature. The elements we suggest here are a
starting point for this work. We used a sum of the included
142 E. Moscoe et al. / Journal of Clinical Epidemiology 68 (2015) 132e143elements to quickly summarize the findings presented in
Table 2, but this does not provide information about the
relative importance of each element, which should be incor-
porated into a quality score. Future studies should adhere to
these guidelines to ensure transparency in reporting and to
increase confidence in study validity.5. Conclusion
In light of RD’s many potential health applications, its
advantages vis-a-vis other study designs, the availability
of required data, and the proliferation of RD in other fields,
RD is currently underutilized in medicine, epidemiology,
and public health. Increased use of RD designs in these
fields could lead to a wide range of novel insights into
causal effects, when randomized controlled experiments
are not feasible or cannot generate the answers to questions
about the effectiveness of interventions implemented under
the imperfect conditions that are pervasive in real-life
health systems. Institutions involved in synthesizing evi-
dence for medical practice and health policy, such as the
Cochrane Collaboration and the GRADE system, should
consider adding RD as a study design that can generate re-
sults of strong causal validity, and not just another observa-
tional study design. Most importantly, researchers in
medicine, epidemiology, and public health should increas-
ingly take advantage of existing cohort data and threshold
treatment assignment rules to generate insights that are
new and, in many cases, will be unlikely to be generated
through other approaches.References
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